Yunnan Botanee Bio-Technology Group Co Ltd (300957) - Total Assets
Based on the latest financial reports, Yunnan Botanee Bio-Technology Group Co Ltd (300957) holds total assets worth CN¥8.29 Billion CNY (≈ $1.21 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Yunnan Botanee Bio-Technology Group Co Ltd - Total Assets Trend (2017–2025)
This chart illustrates how Yunnan Botanee Bio-Technology Group Co Ltd's total assets have evolved over time, based on quarterly financial data. Also see Yunnan Botanee Bio-Technology Group Co L (300957) market capitalisation for the company's overall valuation and market capitalisation.
Yunnan Botanee Bio-Technology Group Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Yunnan Botanee Bio-Technology Group Co Ltd's total assets of CN¥8.29 Billion consist of 70.4% current assets and 29.7% non-current assets. Review Yunnan Botanee Bio-Technology Group Co L balance sheet liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 29.5% |
| Accounts Receivable | CN¥558.97 Million | 6.7% |
| Inventory | CN¥528.46 Million | 6.3% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥551.79 Million | 6.6% |
| Goodwill | CN¥292.50 Million | 3.5% |
Asset Composition Trend (2017–2025)
This chart illustrates how Yunnan Botanee Bio-Technology Group Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See 300957 stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Yunnan Botanee Bio-Technology Group Co Ltd's current assets represent 70.4% of total assets in 2025, a decrease from 91.5% in 2017.
- Cash Position: Cash and equivalents constituted 29.5% of total assets in 2025, down from 52.4% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, an increase from 0.0% in 2017.
- Asset Diversification: The largest asset category is accounts receivable at 6.7% of total assets.
Yunnan Botanee Bio-Technology Group Co Ltd Competitors by Total Assets
Key competitors of Yunnan Botanee Bio-Technology Group Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Colgate Palmolive (India) Limited
NSE:COLPAL
|
India | Rs30.19 Billion |
|
Guangdong Marubi Biotechnology Co
SHG:603983
|
China | CN¥4.63 Billion |
|
C&S Paper Co Ltd
SHE:002511
|
China | CN¥9.17 Billion |
|
Chongqing Baiya Sanitary Products Co
SHE:003006
|
China | CN¥2.10 Billion |
|
Leifheit Aktiengesellschaft
F:LEI
|
Germany | €185.83 Million |
|
Mcphersons Ltd
AU:MCP
|
Australia | AU$116.49 Million |
|
PENTAL LTD
F:81B
|
Germany | €30.26 Million |
|
Rigolleau SA
BA:RIGO
|
Argentina | AR$154.64 Billion |
Yunnan Botanee Bio-Technology Group Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.63 | 6.18 | 8.56 |
| Quick Ratio | 3.25 | 5.51 | 7.95 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥4.20 Billion | CN¥4.29 Billion | CN¥3.86 Billion |
Yunnan Botanee Bio-Technology Group Co Ltd - Advanced Valuation Insights
This section examines the relationship between Yunnan Botanee Bio-Technology Group Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.34 |
| Latest Market Cap to Assets Ratio | 0.23 |
| Asset Growth Rate (YoY) | 0.5% |
| Total Assets | CN¥8.34 Billion |
| Market Capitalization | $1.96 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Yunnan Botanee Bio-Technology Group Co Ltd's assets below their book value (0.23x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Yunnan Botanee Bio-Technology Group Co Ltd's assets grew by 0.5% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Yunnan Botanee Bio-Technology Group Co Ltd (2017–2025)
The table below shows the annual total assets of Yunnan Botanee Bio-Technology Group Co Ltd from 2017 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥8.34 Billion ≈ $1.22 Billion |
+0.46% |
| 2024-12-31 | CN¥8.30 Billion ≈ $1.22 Billion |
+10.61% |
| 2023-12-31 | CN¥7.51 Billion ≈ $1.10 Billion |
+11.72% |
| 2022-12-31 | CN¥6.72 Billion ≈ $983.29 Million |
+15.61% |
| 2021-12-31 | CN¥5.81 Billion ≈ $850.55 Million |
+245.30% |
| 2020-12-31 | CN¥1.68 Billion ≈ $246.32 Million |
+55.31% |
| 2019-12-31 | CN¥1.08 Billion ≈ $158.60 Million |
+41.87% |
| 2018-12-31 | CN¥763.97 Million ≈ $111.79 Million |
+52.23% |
| 2017-12-31 | CN¥501.84 Million ≈ $73.44 Million |
-- |
About Yunnan Botanee Bio-Technology Group Co Ltd
Yunnan Botanee Bio-Technology Group Co.LTD, together with its subsidiaries, engages in the research, development, production, and sale of cosmetics in China and internationally. It operates through Skin Care Products, Medical Instruments, and Makeup segments. The company offers face creams, toners, masks, serums, and lotions; and makeup products, including primers, powders, BB creams, and makeup … Read more